Abstract
Eighteen elderly patients aged 76 years or older with small cell lung cancer were treated with carboplatin (AUC = 4 mg/ml.min, i.v. day 1) and etoposide (70 mg/m2 i.v. day 1-3) and 17 patients were evaluable. The median age of the study population was 77 years (range: 76-81). Eight patients had limited disease (LD) and nine did extensive disease (ED). The overall response rate was 88% for LD patients and 67% for ED patients. Median survival time was 219 days for LD patients and 158 days for ED patients. Grade 3 and 4 leukopenia, neutropenia, thrombocytopenia and anemia occurred in 41%, 76%, 24% and 6% of patients, respectively. There was one treatment-related death due to pneumonitis.
| Original language | English |
|---|---|
| Pages (from-to) | 751-756 |
| Number of pages | 6 |
| Journal | Gan to kagaku ryoho. Cancer & chemotherapy |
| Volume | 29 |
| Issue number | 5 |
| Publication status | Published - May 2002 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Pharmacology
Cite this
Tada, A., Ueoka, H., Kiura, K., Tabata, M., Takemoto, M., Yamane, H., Hiyama, J., Aoe, K., Shibayama, T., Kamei, H., Kawahara, S., Harita, S., Sato, T., Kobayashi, M., Eguchi, K., Hiraki, S., Hiraki, Y., & Tanimoto, M. (2002). Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 29(5), 751-756.